SENIOR LEADERS

高层领导

基本信息

批准号：
7714206
负责人：
MICHELLE M LE BEAU
金额：
$ 19.55万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-07-22 至 2013-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7714206
关键词：
Advisory Committees African American Antineoplastic Agents Basic Science Biological Sciences Cancer Center Chicago Clinical Clinical Sciences Clinical Trials Collaborations Communication Communities Community Outreach Conduct Clinical Trials Contracts Core Facility Development Disease Doctor of Philosophy Ensure Epidemiology Evaluation Faculty Genetic Genome Goals Grant Head and neck structure Hematology Human Resources Individual Informatics International Investigational Drugs Knowledge Leadership Malignant Neoplasms Malignant neoplasm of lung Malignant neoplasm of prostate Minority Molecular Epidemiology of Cancer Patient Care Pediatric Oncology Pharmacogenetics Pharmacogenomics Phase Phenotype Pilot Projects Population Research Positioning Attribute Prevention Radiation Oncology Recruitment Activity Research Research Activity Research Personnel Resource Informatics Resource Sharing Role Signal Transduction Strategic Planning Structure Structure of base of prostate Surgical Oncology Technology Therapeutic Clinical Trial Training Translational Research Trust Universities University of Chicago Cancer Research Center Virginia Work anticancer research biomedical informatics cancer epidemiology cancer health disparity experience gene environment interaction health disparity interest malignant breast neoplasm member oncology outreach program professor programs research facility science education skills

项目摘要

The UCCRC Senior Leadership consists of the Director, two Co-Deputy Directors, and 7 Associate Directors. The composition and structure of this team has changed over the past five years, reflecting UCCRC planning and evaluation activities, new initiatives and approaches at the level of the Biological Sciences Division (BSD), new recruitments, and new UCCRC strategic initiatives and overall goals. In April 2004, Dr. Le Beau succeeded Dr. Vogelzang as UCCRC Director. To facilitate translational research, as well as to optimize integration of both clinical and basic research, Dr. Le Beau appointed two Deputy Directors: Dr. Marsha Rosner, the Charles B. Muggins Professor, Chair of the Ben May Department for Cancer Research and an experienced basic researcher, and Dr. Everett Vokes, the John E. Ultmann Professor and Director of the Section of Hematology/Oncology, PI of the NCI Phase II contract and an experienced clinical researcher. Both Drs. Rosner and Vokes have previously held senior leadership roles within the UCCRC. Dr. Marcy List continues in her role as Associate Director for Administration, and her responsibilities have been expanded. Drs. Greene and Ratain continue in their roles as Associate Director for Basic Sciences, Education and Training, and Associate Director for Clinical Sciences, respectively. To expand our efforts in cancer epidemiology, prevention, and control, we recruited Habibul Ahsan, MD, who assumed the position of UCCRC Associate Director for Population Research in December 2006. To facilitate the enhancement of community outreach programs and recruitment of minorities to clinical trials, as well as to expand our research portfolio in health disparities, Rick Kittles, PhD, was recruited in August 2006 and has assumed the newly-created position of UCCRC Associate Director for Diversity and Community Outreach. Recognizing the need to upgrade informatics activities in support of UCCRC researchers and to train faculty and staff in the use of existing technologies, Yves Lussier, MD, recruited in Jan 2006, was appointed UCCRC Associate Director for Biomedical Informatics. Finally, to oversee and integrate UCCRC core facilities with those of the BSD, Julie Auger, BS, Director of the BSD Office of Shared Research Facilities was appointed UCCRC Associate Director for Core Facilities. The above individuals are members of the Cancer Advisory Committee (CAC), which also includes additional leaders of academic units engaged in cancer research and care of patients with cancer, e.g., Radiation Oncology, Surgical Oncology, and Pediatric Oncology. The CAC oversees all UCCRC activities, including strategic planning, programmatic development, development of shared resources, recruitment, and oversight of the pilot project program.

UCCRC高级领导包括董事，两名共同董事和7名副董事。在过去五年中，该团队的组成和结构发生了变化，反映了UCCRC计划以及评估活动，生物科学部级别的新计划和方法（BSD），新招聘以及新的UCCRC战略计划和整体目标。 2004年4月，Le Beau博士 Vogelzang博士担任UCCRC主任。促进转化研究，并优化 Le Beau博士均融合了临床和基础研究，任命了两位副董事：Marsha博士查尔斯·莫金斯（Charles B. Muggins）教授罗斯纳（Rosner）经验丰富的基础研究员和约翰·E·Ultmann教授兼主任埃弗里特·沃克斯（Everett Vokes）博士血液学/肿瘤学部分，NCI II期合同的PI和经验丰富的临床研究人员。两个博士。罗斯纳（Rosner）和沃克斯（Vokes）此前曾在UCCRC担任高级领导职务。 Marcy博士列表继续担任管理副主任，她的职责已经被扩展。博士。 Greene和Ratain继续担任基础科学副主任，教育和培训，分别是临床科学副主任。扩大我们的努力癌症流行病学，预防和控制，我们招募了医学博士Habibul Ahsan，他担任了职位 UCCRC人口研究副总监于2006年12月。社区外展计划和招募少数民族进行临床试验，并扩大我们的 2006年8月招募了健康差异的研究组合，Rick Kittles，PhD UCCRC多样性和社区外展副总监新创建的职位。认可需要升级信息学活动以支持UCCRC研究人员，并培训教职员工 2006年1月招募的现有技术的使用，医学博士伊夫·卢西尔（Yves Lussier）被任命为UCCRC助理生物医学信息学主管。最后，监督和集成了UCCRC核心设施 BSD，朱莉·奥格尔（Julie Auger），BS，共享研究设施的BSD办公室主任被任命为UCCRC 核心设施副主任。以上个人是癌症咨询委员会（CAC）的成员，其中还包括其他从事癌症患者的癌症研究和护理的学术单位领导者，例如辐射肿瘤学，外科肿瘤学和小儿肿瘤学。 CAC监督所有UCCRC活动，包括战略规划，程序发展，共享资源的发展，招聘和监督试点项目计划。